Product information and disease description Place of product in therapy Disease description Burden of Refractory mucocutaneous herpes simplex virus infection in immunocompromised adults

Economic impact of diagnostic testing

5 evidence topics · 7 sources

Published cost or cost-effectiveness analysis of resistance testing

No evidence found.

Billing codes listed by laboratories for phenotypic resistance testing

Laboratory test	Current Procedural Terminology codes listed
Labcorp test 138370, plaque reduction assay	“87252; 87253”

Billing codes listed by laboratories for genotypic resistance testing

Laboratory test	Current Procedural Terminology codes listed
University of Washington rapid polymerase chain reaction with reflex UL23 sequencing (HSVDRR)	“87529x2”

Laboratory test	Current Procedural Terminology code listed
University of Washington UL23 Sanger sequencing (HSVDR)	“87900”

Medicare Clinical Laboratory Fee Schedule records for the listed codes, fourth-quarter file

Code	Short description in the file	Rate in the file (U.S. dollars)
87252	“Virus inoculation tissue”	“00026.07”
87253	“Virus inoculate tissue addl”	“00020.20”
87254	“Virus inoculation shell via”	“00019.56”
87529	“Hsv dna amp probe”	“00035.09”
87900	“Phenotype infect agent drug”	“00130.35”

“Note: Including a code or payment amount for a particular clinical diagnostic laboratory test doesn't imply Medicare will cover the test.” (opens the source at this quote in a new tab)
“CY 2026 Q4 Release: Updated for October 2026.” (opens the source at this quote in a new tab)

Number of resistance assays ordered in the seven-center United States transplant cohort

“108 patients were tested for antiviral resistance including 73 for acyclovir and foscarnet, 31 for acyclovir only, and 4 for foscarnet only.” (opens the source at this quote in a new tab)

Access to genotypic testing named as an unmet need

“Broader availability of genotypic testing and improved access to novel, more effective, and better-tolerated antivirals represent current unmet needs in this highly vulnerable patient population.” (opens the source at this quote in a new tab)